News with Multimedia
-
Mori Building to Open Azabudai Hills on November 24, 2023
08/08/2023 - 10:30 AM
-
「麻布台ヒルズ」2023年11月24日開業
08/08/2023 - 10:30 AM
-
Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress
08/08/2023 - 04:01 AM
-
Kyocera to Construct New Development Center at Shiga Yasu Campus in Japan
08/07/2023 - 08:05 PM
-
日本発のβ1,3-1,6グルカン「neu REFIX®（ニューリフィックス）」によるデュシェンヌ型筋ジストロフィーに対する緩和アプローチ：初の臨床報告
08/07/2023 - 04:57 PM
-
FPT Software Inks Deal with Japanese Energy Giant Toho Gas
08/07/2023 - 12:00 PM
-
FIELDSTYLE Works Presents “Japan's Largest Recreational Festival” - OUTDOOR & LIFESTYLE FESTA - FIELDSTYLE JAMBOREE to be Held in November 2023!!
08/07/2023 - 09:00 AM
-
Greener, More Nutritious, More Intelligent, Mengniu Leads the New World of the Dairy Industry till 2049
08/06/2023 - 09:54 PM
-
首份同类临床报告显示，日本的Neu-REFIX® Beta 1,3-1,6葡聚糖*有望改变杜氏肌营养不良症的病情
08/05/2023 - 02:35 AM
-
首份同類臨床報告顯示，日本的Neu-REFIX® Beta 1,3-1,6葡聚糖*可望改變裘馨氏肌肉失養症的病情
08/05/2023 - 01:32 AM
-
Riassunto: Nuovo approccio promettente alla Distrofia muscolare di Duchenne con Neu-REFIX® Beta 1,3-1,6 glucan dal Giappone; il primo report medico di questo tipo.
08/05/2023 - 12:08 AM
-
Premier rapport clinique prometteur sur un traitement de fond de la dystrophie musculaire de Duchenne avec Neu-REFIX® Beta 1,3-1,6 glucan* au Japon
08/05/2023 - 12:05 AM
-
Proteintech Accelerates Growth with Expansions in the US and China
08/04/2023 - 11:53 PM
-
Pony.ai and Toyota to Form Joint Venture to Advance Mass Production of L4 Autonomous Vehicles
08/04/2023 - 10:59 PM
-
Promissora abordagem modificadora da distrofia muscular de Duchenne com Neu-REFIX® Beta 1,3-1,6 glucano* do Japão é o primeiro relato clínico desse tipo
08/04/2023 - 09:48 PM